March 1, 2018 / 6:10 AM / 8 months ago

BRIEF-Newron Pharmaceuticals FY Net Loss Narrows To EUR 5.28 Million

March 1 (Reuters) - NEWRON PHARMACEUTICALS SPA:

* FY TOTAL REVENUES SUBSTANTIALLY INCREASED TO EUR 13.4 MILLION FROM EUR 6.7 MILLION (2016)

* FY INCREASED LICENSE INCOME (EUR 10.4 MILLION IN 2017 VERSUS. EUR 3.0 MILLION IN 2016)

* ‍FY NET LOSS EUR 5.28 MILLION VERSUS NET LOSS EUR 15.24​ MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below